LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Market Cap	4.46B -24.8%
Revenue (ttm)	587.50M +11.9%
Net Income	266.77M -2.4%
EPS	0.77 -2.6%
Shares Out	346.75M
PE Ratio	16.75
Forward PE	8.65
Dividend	0.57 (4.47%)
Ex-Dividend Date	May 27, 2026

Volume	145,000
Average Volume	1,039,120
Open	13.15
Previous Close	12.86
Day's Range	12.83 - 13.30
52-Week Range	12.80 - 33.00
Beta	-0.05
RSI	39.36
Earnings Date	Mar 30, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Employees: 370
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2291

Financial Performance

In 2025, HKG:2291's revenue was 527.94 million, an increase of 11.94% compared to the previous year's 471.64 million. Earnings were 239.73 million, a decrease of -2.37%.

Financial numbers in CNY